US plan for $1.6m hepatitis B vaccine study in Africa called ‘highly unethical’
The Trump administration has indicated that it will fund a $1,6m study on hepatitis B vaccination of newborns in the west African country of Guinea-Bissau, where nearly one in five adults live with the virus – a move that researchers call “highly unethical” and “extremely risky”,The news follows an official change in recommendations on hepatitis B vaccines at birth from the US Centers for Disease Control and Prevention (CDC), which called the shots an “individual” decision, despite decades of safe and effective vaccination and no evidence of harm,It is part of sweeping changes to childhood immunizations by the US health secretary, Robert F Kennedy Jr, which have global repercussions – including cutting funding for programs that bring vaccines to countries around the world,“He has a fixed, immutable belief that vaccines cause harm,” said Paul Offit, director of the Vaccine Education Center and an attending physician at Children’s Hospital of Philadelphia.
“He will do everything he can to try and prove that,”The actions taken this year by Kennedy, a longtime anti-vaccine activist, have “a global impact”, said Elizabeth Jacobs, professor emerita at the University of Arizona and a founding member of the grassroots group Defend Public Health,“It is spreading like an infection all its own throughout the globe,”Testing established vaccines in a country with high rates of hepatitis B and a fragile health system “reeks of a neocolonialist attitude” and risks expanding global mistrust of the US and science, said Gavin Yamey, professor of global health at the Duke Global Health Institute,When Kennedy announced in June that the US would end funding to Gavi, the Vaccine Alliance, which has vaccinated more than 1.
2 billion children and saved an estimated 20.6 million lives, he sent shock waves through global health – and he cited an unusual study from 2018 to justify the action.The study made an alarming claim: the diphtheria-tetanus-pertussis (DTP) vaccine caused death in young girls in Guinea-Bissau.It was published by a group of Danish researchers, including a married couple named Peter Aaby and Christine Stabell Benn.But when Kennedy made his announcement in 2025, he did not mention a 2022 paper from some of the same authors on the same topic finding completely different results, essentially nullifying the first study.
“We did not find that early-DTP was associated with increased female mortality as found in a previous study,” the researchers wrote.It is one example of their questionable research, which has drawn criticism from other researchers and journalists examining their findings.Now those same researchers will be the ones carrying out the new study on hepatitis B vaccination in Guinea-Bissau.US funding will go to the Bandim Health Project, led by Aaby and Stabell Benn, at the University of Southern Denmark.Aaby and Stabell Benn did not respond to the Guardian’s inquiries about the details of the five-year study, set to begin in early 2026.
Babies in the randomized, controlled trial will or will not receive the hepatitis B vaccine at birth.Researchers will then compare early-life mortality, illness and development between the groups, according to the award announcement from the CDC.The World Health Organization recommends giving the vaccine to all babies at birth, but Guinea-Bissau has struggled to roll out the shots to every newborn, instead recommending the dose at six weeks of age.The country has pledged to fill that gap and plans on recommending hepatitis B vaccines to all newborns in 2027.It is a major breach of scientific ethics to withhold an intervention that has been proven safe and effective.
“It’s highly unethical to choose to give a vaccine to some children but not others,” Offit said.Yamey noted: “There’s already an RCT [randomized, controlled trial] showing superior outcomes with the birth dose, so why is another one needed?”The study does not appear to be looking at whether the vaccine is more effective at birth, which Jacobs said was “concerning” as “nowhere in this do they say that they’re going to study the efficacy of the vaccine itself.”Instead, the trial will examine whether there are “overall health effects” – not specific outcomes, such as preventing infection from the virus – when the shot is given at birth, according to the Bandim Health Project.“This announcement has set alarm bells ringing in the global health community,” said Martin McKee, professor of European public health at the London School of Hygiene and Tropical Medicine, calling it a symptom of “a policy desperately searching for evidence”.“It is not clear what the research question is.
It seems to be about the safety of the vaccine rather than its effectiveness, but both are already well-established, and to undertake such a study in a population where almost one in five of the adult population has a marker of infection seems extremely risky,” McKee said,He also questioned whether participants could truly give informed consent, given the ethical concerns about how the study is being conducted,In a recent survey, about 18% of Bissau-Guinean adults had hepatitis B, a virus that can lead to cirrhosis or liver cancer, especially among young children,If a baby is infected in the first year of life, there is a 90% chance they will develop cirrhosis or liver cancer; between the ages of one and five, there is a 25% chance,Among adults, about 5% have a chronic infection.
In a recent study of toddlers in Guinea-Bissau, about 11.2% already had hepatitis B infection, which means not enough babies are getting the shots, said Andrew Pollard, professor of paediatric infection and immunity and director of the Oxford Vaccine Group at the University of Oxford.Across sub-Saharan Africa, only about 17% of babies receive the recommended birth dose, he added.“The priority should be to increase vaccination with the birth dose of hepatitis B vaccine and protect more babies from the risk posed by this virus,” Pollard said.In the US, recommending the vaccine at birth to all babies – not just those who appeared to be at risk of infection – caused rates among children to drop precipitously, from 20,000 to about 20 a year.
“We virtually eliminated hepatitis B in children less than 10,” Offit said.Children may be infected at birth, but they may also come into contact with other children and adults carrying the virus – which can remain infectious on surfaces for up to a week.The experts voiced concerns about how the study would take place.It is unusual for a trial like this to take place in Guinea-Bissau instead of the United States or Denmark, they said.“Why on Earth is this study happening in a high-endemic setting where the birth dose matters the most?” Yamey asked.
In Denmark, where only three in 1,000 people have the virus, the shot is not currently recommended at birth either, which means the same study could be conducted there.Denmark also has health registries, making it easier to access complete medical records.Instead, by working in a country with precarious healthcare and high rates of the illness, studies like this may lead to “expanding distrust in global public health”, Jacobs said.The US canceled much of its global aid and research earlier this year, Jacobs said.“In the face of the US canceling all this funding for vulnerable countries, and then it’s still going to pay for this research to be done – that is really worrying,” she said.
“It seems to say we don’t value your lives enough to continue to provide support overall, but we won’t hesitate to experiment with your population,”The study is single-blinded, which means the patients will not know who got the vaccine and who didn’t, but the research team will – which can affect the way they collect and interpret the data,“This means they can stamp their own biases on the results,” Yamey said,And the endpoints – “overall health effects” – are “very squishy”, which leaves the results vulnerable to manipulation, Jacobs said,Henrik Støvring, a professor of statistics and pharmacometrics at Aarhus University who co-wrote about red flags in Bandim Health Project research for the journal Vaccine this month, said “broad hypotheses like these carry a high risk of false positive findings, and in general the research group has previously been reluctant to use appropriate statistical methods to curb such a risk.
”“I think conflicts of interests are always an issue when the donor so explicitly seeks out a research group and funds a study,” Støvring said,The Danish journalist Gunver Lystbæk Vestergård has also written about major issues with research conducted by Aaby and Stabell Benn,After the CDC sparked outrage by changing the recommendation for hepatitis B vaccination with no evidence, Jacobs said, “they’re now funding this to try to give themselves cover for having done that,”“Because Robert F Kennedy Jr is an anti-vaccine zealot, he will somehow contort that study to look like the hepatitis B birth dose causes harm” or that it is better to delay the shots, Offit said,Scientists, doctors and medical organizations are speaking out against Kennedy, he said, but “this is a political problem, and it requires a political solution.
”In the meantime, children will bear the brunt of these decisions, Offit continued: “This breaks my heart,It really does,It’s hard to sleep knowing that children are constantly being put in harm’s way by the administration,”
US plan for $1.6m hepatitis B vaccine study in Africa called ‘highly unethical’
The Trump administration has indicated that it will fund a $1.6m study on hepatitis B vaccination of newborns in the west African country of Guinea-Bissau, where nearly one in five adults live with the virus – a move that researchers call “highly unethical” and “extremely risky”.The news follows an official change in recommendations on hepatitis B vaccines at birth from the US Centers for Disease Control and Prevention (CDC), which called the shots an “individual” decision, despite decades of safe and effective vaccination and no evidence of harm. It is part of sweeping changes to childhood immunizations by the US health secretary, Robert F Kennedy Jr, which have global repercussions – including cutting funding for programs that bring vaccines to countries around the world.“He has a fixed, immutable belief that vaccines cause harm,” said Paul Offit, director of the Vaccine Education Center and an attending physician at Children’s Hospital of Philadelphia
Long waits and ‘unacceptable’ lack of data at NHS gender clinics in England, review finds
Doctors treating vulnerable patients with gender dysphoria have no way of assessing whether the NHS treatment provided has worked because outcomes are not systematically recorded, a damning official inquiry into the clinics has found.Waiting times for a first appointment at NHS adult gender dysphoria clinics (GDCs) in England are projected to reach 15 years unless there are improvements, the review found. The number of people seeking treatment is rising significantly and on average patients are already waiting five years and seven months for a first assessment.The review conducted by Dr David Levy, an NHS medical director and cancer specialist, was commissioned after last year’s Cass report on gender care for children and young people.Levy, an NHS medical director and cancer specialist, took a team to nine NHS England clinics to assess the effectiveness and safety of each service, interviewing staff and patients
Stay at home if you have flu symptoms, experts urge amid fears of second surge
People should stay home over the Christmas period if they have symptoms of flu or Covid, experts have warned amid fears flu cases could see a second surge in the New Year.Flu levels appear to be plateauing, but it is too soon to say whether they have peaked, according to the UK Health Security Agency (UKHSA). As a result, experts are urging people to wash their hands regularly, make sure indoor spaces are well ventilated, get a free vaccination if eligible, and stay home where possible if symptoms develop.An average of 3,140 people were in hospital with flu each day by the end of last week, an increase of 18% compared with the previous week. At the same time last year, an average of 2,629 patients were in hospital, while in 2023 the number was 648
Better to be online than on hold for a GP | Brief letters
As the sole parent of two disabled children who have lots of medical needs, I have found the new GP online booking system an immense improvement (Letters, 12 December). It is efficient and far less stressful for me. My inner‑city practice responds quickly. It is streets ahead of the old system where I was caller No 26 at 9am.Anne McLaughlinManchester Politicians of all stripes have condemned the resident doctors for striking for meaningful progress in getting their pay back to real-terms parity with that prior to the 2008 crash (Officials fear NHS will be hit hard after resident doctors reject latest offer, 15 December)
Badenoch accused of making ‘deeply inaccurate’ claims about violence against women
Kemi Badenoch has been accused of weaponising violence against women and girls and using “dangerous” and “deeply inaccurate” claims in her response to the government’s plan to tackle the issue.In the House of Commons on Thursday, the safeguarding minister, Jess Phillips, introduced the government’s long-awaited strategy to tackle “the national emergency” of violence against women and girls, saying it did something “that none before it ever has” by making tackling it a priority across local and national government, the criminal justice system and the voluntary sector.Phillips told the Commons: “We are calling violence against women and girls the national emergency that it is. We are committing to halve these horrific crimes within a decade, and today we publish the strategy that sets us on that journey.”After the announcement of the strategy – which will focus on preventing radicalisation of young men, stopping abusers and supporting victims – the Conservative leader said plans to tackle misogyny in schools were being introduced only because “some people in Labour” watched the Netflix drama Adolescence, adding that the focus should be on “people, who come from cultures that don’t respect women, coming into our country”
Study finds 10% of over-70s in UK could have Alzheimer’s-like changes in brain
One in 10 people in the UK aged 70 and older could have Alzheimer’s-like changes in their brain, according to the clearest, real-world picture of how common the disease’s brain changes are in ordinary, older people.The detection of the proteins linked with the disease is not a diagnosis. But the findings indicate that more than 1 million over-70s would meet Nice’s clinical criteria for anti-amyloid therapy – a stark contrast to the 70,000 people the NHS has estimated could be eligible if funding were available.Experts, including those from Alzheimer’s Research UK, have said the findings from the first-ever population-based research into the disease have huge potential for early and accurate diagnosis.“High-quality studies like this are crucial to enhancing our understanding of how blood tests for Alzheimer’s could be used in clinical practice,” said David Thomas, the head of policy and public affairs at Alzheimer’s Research UK
UK supermarkets turn to European turkeys as avian flu hits supply
‘Bills keep going higher’: community ‘warm spaces’ on the rise in the UK
‘It can be quite a thankless job’: why driving examiners are quitting
Tinsel and Home Alone back in style as TikTok seeks comfort in #90sChristmas
Stokes vows to remain England captain as McCullum admits regret over Ashes preparations
Dominant Australia defeat England in third Test to retain Ashes – as it happened